125 related articles for article (PubMed ID: 9779468)
1. In vivo generation of chimeras.
Buck KJ; Amara SG
Methods Enzymol; 1998; 296():466-75. PubMed ID: 9779468
[No Abstract] [Full Text] [Related]
2. Structural determinants of neurotransmitter transport using cross-species chimeras: studies on serotonin transporter.
Barker EL; Blakely RD
Methods Enzymol; 1998; 296():475-98. PubMed ID: 9779469
[No Abstract] [Full Text] [Related]
3. Voltammetric studies on kinetics of uptake and efflux at catecholamine transporters.
Danek K; Justice JB
Methods Enzymol; 1998; 296():649-60. PubMed ID: 9779480
[No Abstract] [Full Text] [Related]
4. Cloned catecholamine transporters expressed in polarized epithelial cells: sorting, drug sensitivity, and ion-coupling stoichiometry.
Gu H; Caplan MJ; Rudnick G
Adv Pharmacol; 1998; 42():175-9. PubMed ID: 9327872
[No Abstract] [Full Text] [Related]
5. Probing structure of neurotransmitter transporters by substituted-cysteine accessibility method.
Javitch JA
Methods Enzymol; 1998; 296():331-46. PubMed ID: 9779459
[No Abstract] [Full Text] [Related]
6. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
Pifl C; Giros B; Caron MG
Adv Neurol; 1996; 69():235-8. PubMed ID: 8615133
[No Abstract] [Full Text] [Related]
7. Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function.
Blakely RD; Moore KR; Qian Y
Soc Gen Physiol Ser; 1993; 48():283-300. PubMed ID: 8503051
[No Abstract] [Full Text] [Related]
8. Synthesis of 2beta-acyl-3beta-(substituted naphthyl)-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites.
Davies HM; Gilliatt V; Kuhn LA; Saikali E; Ren P; Hammond PS; Sexton T; Childers SR
J Med Chem; 2001 May; 44(10):1509-15. PubMed ID: 11334561
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter mutants, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development.
Uhl G; Lin Z; Metzger T; Dar DE
Methods Enzymol; 1998; 296():456-65. PubMed ID: 9779467
[No Abstract] [Full Text] [Related]
10. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
[TBL] [Abstract][Full Text] [Related]
11. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.
Giros B; Wang YM; Suter S; McLeskey SB; Pifl C; Caron MG
J Biol Chem; 1994 Jun; 269(23):15985-8. PubMed ID: 8206893
[TBL] [Abstract][Full Text] [Related]
12. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins.
Ramamoorthy S; Melikian HE; Qian Y; Blakely RD
Methods Enzymol; 1998; 296():347-70. PubMed ID: 9779460
[No Abstract] [Full Text] [Related]
14. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
15. Baculovirus-mediated expression of neurotransmitter transporters.
Tate CG
Methods Enzymol; 1998; 296():443-55. PubMed ID: 9779466
[No Abstract] [Full Text] [Related]
16. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations.
Earles C; Wayment H; Green M; Schenk JO
Methods Enzymol; 1998; 296():660-75. PubMed ID: 9779481
[No Abstract] [Full Text] [Related]
17. Molecular cloning of neurotransmitter transporter genes: beyond coding region of cDNA.
Vandenbergh DJ
Methods Enzymol; 1998; 296():498-514. PubMed ID: 9779470
[No Abstract] [Full Text] [Related]
18. Discrete structural domains and cell-specific expression determine functional selectivity of the dopamine and norepinephrine transporters.
Buck KJ; Lorang D; Amara SG
NIDA Res Monogr; 1996; 161():154-75. PubMed ID: 8784850
[TBL] [Abstract][Full Text] [Related]
19. Restriction site-independent formation of chimeras from homologous neurotransmitter-transporter cDNAs.
Moore KR; Blakely RD
Biotechniques; 1994 Jul; 17(1):130-5, 137. PubMed ID: 7946295
[TBL] [Abstract][Full Text] [Related]
20. Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.
Prisinzano T; Greiner E; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2002 Sep; 45(19):4371-4. PubMed ID: 12213078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
